Gene · 833
Papers4,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 4,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting and cytotoxicity of chimeric antigen receptor T cells grafted with PD1 extramembrane domain. | Exp Hematol Oncol | 2023 | 37777797 | PubTator, text mining | PubMed |
| A dendritic/tumor fusion cell vaccine enhances efficacy of nanobody-based CAR-T cells against solid tumor. | Theranostics | 2023 | 37771772 | PubTator, text mining | PubMed |
| Preclinical assessment of a novel human antibody VH domain targeting mesothelin as an antibody-drug conjugate. | Mol Ther Oncolytics | 2023 | 37771390 | PubTator, text mining | PubMed |
| A potential therapeutic target: The role of neutrophils in the central nervous system. | Brain Behav Immun Health | 2023 | 37767236 | PubTator, text mining | PubMed |
| Journal Club: Anti-CD19 Chimeric Antigen Receptor T Cell Therapy for Refractory Systemic Lupus Erythematosus. | ACR Open Rheumatol | 2023 | 37766597 | PubTator, text mining | PubMed |
| Emerging Immunotherapy Approaches for Treating Prostate Cancer. | Int J Mol Sci | 2023 | 37762648 | PubTator, text mining | PubMed |
| Cellular and Molecular Mechanisms of the Tumor Stroma in Colorectal Cancer: Insights into Disease Progression and Therapeutic Targets. | Biomedicines | 2023 | 37760801 | PubTator, text mining | PubMed |
| Bispecific T-Cell Engagers and Chimeric Antigen Receptor T-Cell Therapies in Glioblastoma: An Update. | Curr Oncol | 2023 | 37754534 | PubTator, text mining | PubMed |
| Intelligent tunable CAR-T cell therapy leads the new trend. | Synth Syst Biotechnol | 2023 | 37753197 | PubTator, text mining | PubMed |
| Natural killer cells and their exosomes in viral infections and related therapeutic approaches: where are we? | Cell Commun Signal | 2023 | 37749597 | PubTator, text mining | PubMed |
| How super is supersulfide?: Reconsidering persulfide reactivity in cellular biology. | Redox Biol | 2023 | 37748320 | PubTator, text mining | PubMed |
| Single domain Camelid antibody fragments for molecular imaging and therapy of cancer. | Front Oncol | 2023 | 37746282 | PubTator, text mining | PubMed |
| Editorial: Translation of genetically engineered T cells in cancer immunotherapy. | Front Immunol | 2023 | 37744369 | PubTator, text mining | PubMed |
| Functional enrichment analysis of LYSET and identification of related hub gene signatures as novel biomarkers to predict prognosis and immune infiltration status of clear cell renal cell carcinoma. | J Cancer Res Clin Oncol | 2023 | 37740762 | PubTator, text mining | PubMed |
| Camel nanobody-based B7-H3 CAR-T cells show high efficacy against large solid tumours. | Nat Commun | 2023 | 37739951 | PubTator, text mining | PubMed |
| The inducible secreting TLR5 agonist, CBLB502, enhances the anti-tumor activity of CAR133-NK92 cells in colorectal cancer. | Cancer Biol Med | 2023 | 37731205 | PubTator, text mining | PubMed |
| The role of tumor immune microenvironment in chordoma: promising immunotherapy strategies. | Front Immunol | 2023 | 37720221 | PubTator, text mining | PubMed |
| Therapeutic strategies targeting folate receptor α for ovarian cancer. | Front Immunol | 2023 | 37711615 | PubTator, text mining | PubMed |
| Autologous, allogeneic hematopoietic cell transplantation and CAR-T/NK therapy: what is their real importance in PTCL? | Front Oncol | 2023 | 37711206 | PubTator, text mining | PubMed |
| Refining chimeric antigen receptors via barcoded protein domain combination pooled screening. | Mol Ther | 2023 | 37705245 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/833/papers?page=20